美国专利US20010001834A1 Endoluminal device exhibiting improved endothelialization and method of manufacture thereof

专利PDF首页>>美国专利

专利附录

专利说明

权利要求

类似技术

同族专利

引用文献

法律状态

优先权

专利摘要:
An implantable endoluminal device which is fabricated from materials which present a blood or body fluid and tissue contact surface which has controlled heterogeneities in material constitution. An endoluminal stent which is made of a material having controlled heterogeneities in the stent material along the blood flow surface of the stent and the method of fabricating the stent using vacuum deposition methods.
公开号:US20010001834A1
申请号:US09/745,304
申请日:2000-12-22
公开日:2001-05-24
发明作者:Julio Palmaz；Eugene Sprague；Cristina Simon；Denes Marton；Roger Wiseman；Christopher Banas
申请人:Palmaz Julio C.；Sprague Eugene A.；Cristina Simon；Denes Marton；Wiseman Roger W.；Banas Christopher E.；
IPC主号:A61F2-82

专利说明:
[0001] This application is a divisional application and corresponds to and claims priority of pending U.S. utility patent application, Ser. No. 09/433,929, filed Nov. 19, 1999. [0001] BACKGROUND OF THE INVENTION
[0002] The present invention relates generally to implantable endoluminal medical devices which contact biological fluids and tissues on at least one surface of the medical device. More particularly, the present invention relates to endoluminal stents which are implanted into anatomical passageways using minimally invasive techniques. Endoluminal stents are frequently used post-angioplasty in order to provide a structural support for a blood vessel and reduce the incidence of restenosis following percutaneous balloon angioplasty. A principal example of the present invention are endovascular stents which are introduced to a site of disease or trauma within the body's vasculature from an introductory location remote from the disease or trauma site using an introductory catheter, passed through the vasculature communicating between the remote introductory location and the disease or trauma site, and released from the introductory catheter at the disease or trauma site to maintain patentency of the blood vessel at the site of disease or trauma. [0002]
[0003] While the use of endoluminal stents has successfully decreased the rate of restenosis in angioplasty patients, it has been found that a significant restenosis rate continues to exist even with the use of endoluminal stents. It is generally believed that the post-stenting restenosis rate is due, in major part, to a failure of the endothelial layer to regrow over the stent and the incidence of smooth muscle cell-related neo-intimal growth on the luminal surfaces of the stent. Injury to the endothelium, the natural nonthrombogenic lining of the arterial lumen, is a significant factor contributing to restonisis at the situs of a stent. Endothelial loss exposes thrombogenic arterial wall proteins, which, along with the generally thrombogenic nature of many prosthetic materials, such as stainless steel, titanium, tantalum, Nitinol, etc. customarily used in manufacturing stents, initiates platelet deposition and activation of the coagulation cascade, which results in thrombus formation, ranging from partial covering of the luminal surface of the stent to an occlusive thrombus. Additionally, endothelial loss at the site of the stent has been implicated in the development of neointimal hyperplasia at the stent situs. Accordingly, rapid re-endothelialization of the arterial wall with concomitant endothelialization of the body fluid or blood contacting surfaces of the implanted device, is considered critical for maintaining vasculature patency and preventing low-flow thrombosis. [0003]
[0004] At present, most endoluminal stents are manufactured of stainless steel, which is known to be thrombogenic. In order to reduce the thrombogenicity of the stainless steel and to maintain sufficient dimensional profiles for catheter delivery, most stents minimize the metal surface area which contacts blood, in order to minimize thrombus formation after implantation. Thus, in order to reduce the thrombogenic response to stent implantation, as well as reduce the formation of neointimal hyperplasia, it would be advantageous to increase the rate at which endothelial cells from endothelium proximal and distal to the stent situs, migrate onto and the endothelial coverage of the luminal surface of the stent which is in contact with blood flow through the vasculature. [0004]
[0005] The surface of a solid, homogeneous material can be conceptualized as having unsaturated inter-atomic and intermolecular bonds forming a reactive plane ready to interact with the environment. In practice, a perfectly clean surface is unattainable because of immediate adsorption of airborne species, upon exposure to ambient air, of O, O[0005] ₂, CO₂, SO₂, NO, hydrocarbons and other more complex reactive molecules. Reaction with oxygen implies the formation of oxides on a metal surface, a self-limiting process, known as passivation. An oxidized surface is also reactive with air, by adsorbing simple, organic airborne compounds. Assuming the existence of bulk material of homogeneous subsurface and surface composition, oxygen and hydrocarbons may adsorb homogeneously. Therefore, further exposure to another environment, such as the vascular compartment, may be followed by a uniform biological response.
[0006] Current metallic vascular devices, such as stents, are made from bulk metals made by conventional methods, and stent precursors, such as hypotubes, are made with many steps each of which introduce processing aides to the metals. For example, olefins trapped by cold drawing and transformed into carbides or elemental carbon deposit by heat treatment, typically yield large carbon rich areas in 316L stainless steel tubing manufactured by cold drawing process. The conventional stents have marked surface and subsurface heterogeneity resulting from manufacturing processes (friction material transfer from tooling, inclusion of lubricants, chemical segregation from heat treatments). This results in formation of surface and subsurface inclusions with chemical composition and, therefore, reactivity different from the bulk material. Oxidation, organic contamination, water and electrolytic interaction, protein adsorption and cellular interaction may, therefore, be altered on the surface of such inclusion spots. Unpredictable distribution of inclusions such as those mentioned above provide an unpredictable and uncontrolled heterogeneous surface available for interaction with plasma proteins and cells. Specifically, these inclusions interrupt the regular distribution pattern of surface free energy and electrostatic charges on the metal surface that determine the nature and extent of plasma protein interaction. Plasma proteins deposit nonspecifically on surfaces according to their relative affinity for polar or non-polar areas and their concentration in blood. A replacement process known as the Vroman effect, Vroman L. [0006] The importance of surfaces in contact phase reactions, Seminars of Thrombosis and Hemostasis 1987;13(1):79-85, determines a time-dependent sequential replacement of predominant proteins at an artificial surface, starting with albumin, following with IgG, fibrinogen and ending with high molecular weigh kininogen. Despite this variability, some of the adsorbed proteins have receptors available for cell attachment and therefore constitute adhesive sites. Examples are: fibrinogen glycoprotein receptor IIbIIIa for platelets and fibronectin RGD sequence for many blood activated cells. Since the coverage of an artificial surface with endothelial cells is a favorable end-point in the healing process, to favor endothelialization is desirable in implantable vascular device manufacture.
[0007] Normally, endothelial cells (EC) migrate and proliferate to cover denuded areas until confluence is achieved. Migration, quantitatively more important than proliferation, proceeds under normal blood flow roughly at a rate of 25 μm/hr or 2.5 times the diameter of an EC, which is nominally 10 μm. EC migrate by a rolling motion of the cell membrane, coordinated by a complex system of intracellular filaments attached to clusters of cell membrane attachment, integrin receptors, specifically focal contact points. The integrins within the focal contact sites are expressed according to complex signaling mechanisms and eventually couple to specific amino acid sequences in substrate adhesion molecules (such as RGD, mentioned above). An EC has roughly 16-22% of its cell surface represented by integrin clusters Davies P. F., Robotewskyi A., Griem M. L. [0007] Endothelial cell adhesion in real time. J. Clin. Invest. 1993;91:2640-2652, Davies, P. F., Robotewski, A., Griem, M. L., Qualitiative studies of endothelial cell adhesion, J. Clin. Invest. 1994;93:2031-2038. This is a dynamic process, which implies more than 50% remodeling in 30 minutes. The focal adhesion contacts vary in size and distribution, but 80% of them measure less than 6 μm², with the majority of them being about 1 μm², and tend to elongate in the direction of flow and concentrate at leading edges of the cell. Although the process of recognition and signaling to determine specific attachment receptor response to attachment sites is incompletely understood, regular availability of attachment sites, more likely than not, would favorably influence attachment and migration. Irregular or unpredictable distribution of attachment sites, that might occur as a result of various inclusions, with spacing equal or smaller to one whole cell length, is likely to determine alternating hostile and favorable attachment conditions along the path of a migrating cell. These conditions may vary from optimal attachment force and migration speed to insufficient holding strength to sustain attachment, resulting in cell slough under arterial flow conditions. Due to present manufacturing processes, current implantable vascular devices exhibit such variability in surface composition as determined by surface sensitive techniques such as atomic force microscopy, X-ray photoelectron spectroscopy and time of flight secondary ion-mass spectroscopy.
[0008] There have been numerous attempts to increase endothelialization of implanted stents, including covering the stent with a polymeric material (U.S. Pat. No. 5,897,911), imparting a diamond-like carbon coating onto the stent (U.S. Pat. No. 5,725,573), covalently binding hydrophobic moieties to a heparin molecule (U.S. Pat. No. 5,955,588), coating a stent with a layer of blue to black zirconium oxide or zirconium nitride (U.S. Pat. No. 5,649,951), coating a stent with a layer of turbostratic carbon (U.S. Pat. No. 5,387,247), coating the tissue-contacting surface of a stent with a thin layer of a Group VB metal (U.S. Pat. No. 5,607,463), imparting a porous coating of titanium or of a titanium alloy, such as Ti—Nb—Zr alloy, onto the surface of a stent (U.S. Pat. No. 5,690,670), coating the stent, under ultrasonic conditions, with a synthetic or biological, active or inactive agent, such as heparin, endothelium derived growth factor, vascular growth factors, silicone, polyurethane, or polytetrafluoroethylene, U.S. Pat. No. 5,891,507), coating a stent with a silane compound with vinyl functionality, then forming a graft polymer by polymerization with the vinyl groups of the silane compound (U.S. Pat. No. 5,782,908), grafting monomers, oligomers or polymers onto the surface of a stent using infrared radiation, microwave radiation or high voltage polymerization to impart the property of the monomer, oligomer or polymer to the stent (U.S. Pat. No. 5,932,299). Thus, the problems of thrombogenicity and re-endothelialization associated with stents have been addressed by the art in various manners which cover the stent with either a biologically active or an inactive covering which is less thrombogenic than the stent material and/or which has an increase capacity for promoting re-endothelialization of the stent situs. These solutions, however, all require the use of existing stents as substrates for surface derivatization or modification, and each of the solutions result in a biased or laminate structure built upon the stent substrate. These prior art coated stents are susceptible to delamination and/or cracking of the coating when mechanical stresses of transluminal catheter delivery and/or radial expansion in vivo. Moreover, because these prior art stents employ coatings applied to stents fabricated in accordance with conventional stent formation techniques, e.g., cold-forming metals, the underlying stent substrate is characterized by uncontrolled heterogeneities on the surface thereof. Thus, coatings merely are laid upon the heterogeneous stent surface, and inherently conform to the heterogeneities in the stent surface and mirror these heterogeneities at the blood contact surface of the resulting coating. This is conceptually similar to adding a coat of fresh paint over an old coating of blistered paint, the fresh coating will conform to the blistering and eventually, itself, blister and delaminate from the underlying substrate. [0008]
[0009] The current invention entails creating materials specifically designed for manufacture of stents and other intravascular devices. Manufacture of stents and other intravascular devices is controlled to attain a regular, homogeneous atomic and molecular pattern of distribution along their surface. This avoids the marked variations in surface composition, would create a predictable oxidation and organic adsorption pattern and would have a predictable interaction with water, electrolytes, proteins and cells. Particularly, EC migration would be supported by a homogeneous distribution of binding domains which serve as natural or implanted cell attachment sites, in order to promote unimpeded migration and attachment. Based on observed EC attachment mechanisms such binding domains should have a repeating pattern along the blood contact surface of no less than 1 μm radius and 2 μm border to border spacing between binding domains. Ideally, the inter-binding domain spacing is less than the nominal diameter of an endothelial cell in order to ensure that at any given time, a portion of an endothelial cell is in proximity to a binding domain. [0009] SUMMARY OF THE INVENTION
[0010] In accordance with the present invention, there is provided an implantable endoluminal device which is fabricated from materials which present a blood contact surface which is substantially homogeneous in material constitution. More particularly, the present invention provides an endoluminal stent which is made of a material having controlled heterogeneities along the blood flow surface of the stent. The heterogeneities which are controlled in the present invention include: grain size, grain phase, grain material composition, stent-material composition, and surface topography at the blood flow surface of the stent. Additionally, the present invention provides methods of making an endoluminal stent having controlled heterogeneities in the stent material along the blood flow surface of the stent. [0010] BRIEF DESCRIPTION OF THE FIGURES
[0011] FIG. 1 is a diagrammatic representation of controlled heterogeneities in the inventive stent. [0011]
[0012] FIG. 2 is a micrograph of uncontrolled heterogeneities present in prior art stent material. [0012] DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0013] Blood protein interaction with surfaces of endoluminal devices appears to be an initial step in a chain of events leading to tissue incorporation of the endovascular device. The present invention is based, in part, upon the relationship between surface energy of the material used to make the endoluminal device and protein adsorption at the surface of the endoluminal device. The present inventors have found that a relationship exists between surface free energy and protein adsorption on metals commonly used in fabrication of endoluminal devices. In addition, specific electrostatic forces resident on the surface of metal endoluminal stents have been found to influence blood interactions with the stent surface and the vascular wall. [0013]
[0014] In accordance with the present invention there is provided a stent which is fabricated of a material having substantially homogeneous surface properties, specifically surface energy and electrostatic charge, across the blood contact surface of the stent. Current manufacturing methods for fabricating endoluminal stents fail to achieve the desired material properties of the present invention. As discussed above, stents are fabricated from bulk metals which are processed in a manner which introduces processing aides to the metal. Presently, stents are made from hypotubes formed from the bulk metals, by machining a series of slots or patterns into the hyptotube to accommodate radial expansion into a stainless steel metal tube, or by weaving wires into a mesh pattern. According to the present invention, a stent with a substantially homogeneous metal constitution, exhibiting substantially homogeneous surface properties is made by imparting a stent pattern, suitable for making either a balloon expandable or self expanding stent, onto a substrate and depositing stent-forming metal onto the stent pattern by a deposition methodology which yields a metal having controlled heterogeneities. Suitable deposition methodologies, as are known in the microelectronic and vacuum coating fabrication arts and incorporated herein by reference, are plasma deposition and physical vapor deposition which are utilized to impart a metal layer onto the stent pattern. [0014]
[0015] The present invention consists of a stent made of a bulk material having controlled heterogeneities on the luminal surface thereof. Heterogeneities are controlled by fabricating the bulk material of the stent to have defined grain sizes which yield areas or sites along the surface of the stent having optimal protein binding capability. The characteristically desirable properties of the inventive stent are: (a) optimum mechanical properties consistent with or exceeding regulatory approval criteria, (b) minimization of defects, such as cracking or pin hole defects, (c) a fatigue life of 400 MM cycles as measured by simulated accelerated testing, (d) corrosion resistance, (e) biocompatibility without having biologically significant impurities in the material, (f) a substantially non-frictional abluminal surface to facilitate atraumatic vascular crossing and tracking and compatible with transcatheter techniques for stent introduction, (g) radiopaque at selected sites and MRI compatible, (h) have an luminal surface which is optimized for surface energy and microtopography, (i) minimal manufacturing and material cost consistent with achieving the desired material properties, and (j) high process yields. [0015]
[0016] In accordance with the present invention, the foregoing properties are achieved by fabricating a stent by the same metal deposition methodologies as are used and standard in the microelectronics and nano-fabrication vacuum coating arts, and which are hereby incorporated by reference. In accordance with the present invention, the preferred deposition methodologies include ion-beam assisted evaporative deposition and sputtering techniques. In ion beam-assisted evaporative deposition it is preferable to employ dual and simultaneous thermal electron beam evaporation with simultaneous ion bombardment of the substrate using an inert gas, such as argon, xenon, nitrogen or neon. Bombardment with an inert gas, such as argon ions serves to reduce void content by increasing the atomic packing density in the deposited material during deposition. The reduced void content in the deposited material allows the mechanical properties of that deposited material to be similar to the bulk material properties. Deposition rates up to 20 nm/sec are achievable using ion beam-assisted evaporative deposition techniques. [0016]
[0017] When sputtering techniques are employed, a 200 micron thick stainless steel film may be deposited within about four hours of deposition time. With the sputtering technique, it is preferable to employ a cylindrical sputtering target, a single circumferential source which concentrically surrounds the substrate which is held in a coaxial position within the source. Alternate deposition processes which may be employed to form the stent in accordance with the present invention are cathodic arc, laser ablation, and direct ion beam deposition. When employing vacuum deposition methodologies, the crystalline structure of the deposited film affects the mechanical properties of the deposited film. These mechanical properties of the deposited film may be modified by post-process treatment, such as by, for example, annealing, high pressure treatment or gas quenching. [0017]
[0018] Materials to make the inventive stents are chosen for their biocompatibility, mechanical properties, i.e., tensile strength, yield strength, and their ease of deposition include the following: elemental titanium, vanadium, aluminum, nickel, tantalum, zirconium, chromium, silver, gold, silicon, magnesium, neobium, scandium, platinum, cobalt, palladium, manganese, molybdenum and alloys thereof, such as zirconium-titanium-tantalum alloys, nitinol, and stainless steel. [0018]
[0019] During deposition, the chamber pressure, the deposition pressure and the partial pressure of the process gases are controlled to optimize deposition of the desired species onto the substrate. As is known in the microelectronic fabrication, nano-fabrication and vacuum coating arts, both the reactive and non-reactive gases are controlled and the inert or non-reactive gaseous species introduced into the deposition chamber are typically argon and nitrogen. The substrate may be either stationary or moveable, either rotated about its longitudinal axis, or moved in an X-Y plane within the reactor to facilitate deposition or patterning of the deposited material onto the substrate. The deposited material maybe deposited either as a uniform solid film onto the substrate, or patterned by (a) imparting either a positive or negative pattern onto the substrate, such as by etching or photolithography techniques applied to the substrate surface to create a positive or negative image of the desired pattern or (b) using a mask or set of masks which are either stationary or moveable relative to the substrate to define the pattern applied to the substrate. Patterning may be employed to achieve complex finished geometries of the resultant stent, both in the context of spatial orientation of the pattern as well as the material thickness at different regions of the deposited film, such as by varying the wall thickness of the material over its length to thicken sections at proximal and distal ends of the stent to prevent flaring of the stent ends upon radial expansion of the stent. [0019]
[0020] The stent may be removed from the substrate after stent formation by any of a variety of methods. For example, the substrate may be removed by chemical means, such as etching or dissolution, by ablation, by machining or by ultrasonic energy. Alternatively, a sacrificial layer of a material, such as carbon or aluminum, may be deposited intermediate the substrate and the stent and the sacrificial layer removed by melting, chemical means, ablation, machining or other suitable means to free the stent from the substrate. [0020]
[0021] The resulting stent may then be subjected to post-deposition processing to modify the crystalline structure, such as by annealing, or to modify the surface topography, such as by etching to affect and control the heterogeneities on the blood flow surface of the stent. [0021] EXAMPLE 1 Stent Formation By Sputtering
[0022] A ceramic cylindrical substrate is introduced into a deposition chamber with capabilities of glow discharge substrate cleaning and sputter deposition of carbon and stainless steel. The deposition chamber is evacuated to a pressure less than or equal to 2×10[0022] ⁻⁷Torr. Pre-cleaning of the substrate is conducted under vacuum by glow discharge. The substrate temperature is controlled to achieve a temperature between about 300 and 1100 degrees Centigrade. A bias voltage between −1000 and +1000 volts is applied to the substrate sufficient to cause energetic species arriving at the surface of the substrate to have a hyperthermal energy between 0.1 eV and about 700 eV, preferably between 5-50 eV. The deposition sources are circumferential and are oriented to deposit from the target circumferentially about the substrate.
[0023] During deposition, the deposition pressure is maintained between 0.1 and 10 mTorr. A sacrificial carbon layer of substantially uniform thickness (±5%) between 10 and 500 Angstroms is deposited circumferentially on the substrate. After depositing the carbon layer, a cylindrical film of stainless steel is deposited onto the sacrificial carbon layer on the cylindrical substrate at a deposition rate between about 10 to 100 microns/hour. After formation of the stainless steel film, the substrate is removed from the deposition chamber and heated to volatilize the intermediate sacrificial carbon layer between the substrate and the film. After removing the carbon intermediate layer, the stainless steel film is removed from the substrate and exhibits material properties similar to the bulk stainless steel target and surface properties characterized by controlled heterogeneities in grain size, material composition and surface topography. A series of patterns are then machined into the resultant stainless steel film to form a stent by electrical discharge machining (EDM) or laser cutting the film. [0023] EXAMPLE 2 Stent Formation by Sputtering
[0024] The same operating conditions are followed as in Example 1, except that the substrate is tubular and selected to have a coefficient of thermal expansion different than that of the resultant stent. No intermediate layer of sacrificial carbon is deposited onto the substrate, and the outer surface of the substrate is etched with a pattern of recesses defining a desired stent pattern. The substrate is mounted onto a rotational jig within the deposition chamber and rotated at a uniform rate during deposition. Tantalum is used as the target material and deposited into the recesses of the substrate from a single stationary source. After deposition, the temperature of the substrate and the deposited stent are controlled to impart diametric differential in the substrate and stent and permit removal of the stent from the substrate. [0024] EXAMPLE 3 Stent Formation by Ion Beam-assisted Evaporative Deposition
[0025] A cylindrical substrate is introduced into a deposition chamber which has capabilities of: substrate rotation and precise positioning, glow discharge substrate cleaning, ion beam-assisted evaporative deposition, and cylindrical magnetron sputtering. The deposition sources are (a) dual electron beam evaporative sources placed adjacent one another at the base of the deposition chamber at a fixed distance from the substrate, these are used with simultaneous argon ion impingement onto the substrate from a controlled ion beam source, and (b) a cylindrical magnetron sputtering source with a carbon target capable of circumferentially coating a carbon sacrificial layer of substantially uniform thickness of between 10 and 200 Angstroms onto the substrate. [0025]
[0026] The substrate temperature is controlled to achieve a substrate temperature between about 300 and 1100 degrees Centigrade. The deposition chamber is evacuated to a pressure less than or equal to 2×10[0026] ⁻⁷Torr. A pre-cleaning of the substrate is conducted under vacuum by glow discharge. The substrate is rotated to ensure uniform cleaning and subsequent uniform deposition thickness. After cleaning the substrate is moved into the magnetron and coated with the carbon layer. The substrate is then moved into position to receive the stent-forming metal coating with simultaneous ion bombardment. One electron beam evaporation source contains titanium while the other source contains nickel. The evaporation rates of each of the titanium and nickel evaporation sources are separately controlled to form a nitinol alloy on the substrate as the stent-forming metal. EXAMPLE 4 Planar Deposition of Stent
[0027] The same operating conditions of Example 3 are followed, except that a planar substrate is used. The deposition source is a single electron beam evaporation source containing platinum and is used with simultaneous argon ion impingement onto the substrate from a controlled ion beam source. [0027]
[0028] The substrate temperature is controlled to achieve a substrate temperature between about 300 and 1100 degrees Centigrade. The deposition chamber is evacuated to a pressure less than or equal to 2×10[0028] ⁻⁷Torr. A pre-cleaning of the substrate is conducted under vacuum by glow discharge. After cleaning the substrate is moved into position within the deposition chamber and coated with platinum from the electron beam evaporation source with simultaneous argon ion bombardment, with the electron beam evaporation source passing platinum through a pattern mask corresponding to a stent pattern which is interposed between the source and the substrate to pass a pattern of platinum onto the substrate.
[0029] After deposition, the patterned stent is removed from the substrate and rolled about a forming substrate to a cylindrical shape and opposing ends of the planar stent material are brought into juxtaposition with one another and may be attached by laser welding or left uncoupled. [0029]
[0030] While the invention has been described with reference to its preferred embodiments, those of ordinary skill in the relevant arts will understand and appreciate that the present invention is not limited to the recited preferred embodiments, but that various modifications in material selection, deposition methodology, manner of controlling the material heterogeneities of the deposited stent material, and deposition process parameters may be employed without departing from the invention, which is to be limited only by the claims appended hereto. [0030]

权利要求:
Claims (10)
[1" id="US-20010001834-A1-CLM-00001] 1. A method of manufacturing an endoluminal stent capable of radially expanding from a first diameter to a second diameter, comprising the steps of:
a. providing a substrate having an exterior surface capable of accommodating metal deposition thereupon;
b. depositing a stent-forming metal onto the substrate by a vacuum deposition method;
c. removing the substrate from the endoluminal stent formed thereupon.
[2" id="US-20010001834-A1-CLM-00002] 2. The method according to
claim 1 , wherein step (a) further comprises the step of imparting a pattern onto the exterior surface of the substrate.
[3" id="US-20010001834-A1-CLM-00003] 3. The method according to
claim 2 , wherein step (b) further comprises the step of depositing the stent-forming metal onto the pattern onto the substrate.
[4" id="US-20010001834-A1-CLM-00004] 4. The method according to
claim 1 , further comprises the step of depositing a sacrificial layer of a material onto the substrate prior to step (b).
[5" id="US-20010001834-A1-CLM-00005] 5. The method according to
claim 1 , wherein step (b) is conducted by ion beam-assisted evaporative deposition.
[6" id="US-20010001834-A1-CLM-00006] 6. The method according to
claim 1 , wherein step (b) is conducted by sputtering.
[7" id="US-20010001834-A1-CLM-00007] 7. The method according to
claim 5 , wherein the ion beam-assisted evaporative deposition is conducted in the presence of an inert gas.
[8" id="US-20010001834-A1-CLM-00008] 8. The method according to
claim 1 , wherein the substrate is a cylindrical substrate.
[9" id="US-20010001834-A1-CLM-00009] 9. The method according to
claim 1 , wherein the substrate is a planar substrate.
[10" id="US-20010001834-A1-CLM-00010] 10. The method according to
claim 7 , wherein the inert gas is selected from the group consisting of argon, xenon, nitrogen and neon.

类似技术:

公开号 | 公开日 | 专利标题

US6820676B2|2004-11-23|Endoluminal device exhibiting improved endothelialization and method of manufacture thereof

US10363125B2|2019-07-30|Method of making implantable medical devices having controlled surface properties

US10945828B2|2021-03-16|Self-supporting laminated films, structural materials and medical devices manufactured therefrom and methods of making same

US20010032013A1|2001-10-18|Self-supporting laminated films, structural materials and medical devices manufactured therefrom and method of making same

CA2616781C|2012-01-10|Endoluminal device exhibiting improved endothelialization and method of manufacture thereof

同族专利:

公开号 | 公开日

ES2311000T3|2009-02-01|

AT401043T|2008-08-15|

AU1616501A|2001-05-30|

US20050072544A1|2005-04-07|

US6379383B1|2002-04-30|

AU783336B2|2005-10-20|

EP1990028A2|2008-11-12|

DE60039530D1|2008-08-28|

EP1990028A3|2013-06-12|

EP1233725A1|2002-08-28|

WO2001035865A1|2001-05-25|

CA2390942A1|2001-05-25|

CA2390942C|2008-03-11|

EP1233725B1|2008-07-16|

US6820676B2|2004-11-23|

US7625594B2|2009-12-01|

JP2004500167A|2004-01-08|

引用文献:

公开号 | 申请日 | 公开日 | 申请人 | 专利标题

US20050197689A1|2004-03-02|2005-09-08|Masoud Molaei|Medical devices including metallic films and methods for making same|

US20050197687A1|2004-03-02|2005-09-08|Masoud Molaei|Medical devices including metallic films and methods for making same|

US20050197690A1|2004-03-02|2005-09-08|Masoud Molaei|Medical devices including metallic films and methods for making same|

US20050232968A1|2002-09-26|2005-10-20|Advanced Bio Prosthetic Surfaces, Ltd.|Implantable materials having engineered surfaces and method of making same|

US20060142845A1|2004-12-29|2006-06-29|Masoud Molaei|Medical devices including metallic films and methods for making same|

US20060142838A1|2004-12-29|2006-06-29|Masoud Molaei|Medical devices including metallic films and methods for loading and deploying same|

US20060142842A1|2004-12-29|2006-06-29|Masoud Molaei|Medical devices including metallic films and methods for making same|

US20060142851A1|2004-12-29|2006-06-29|Masoud Molaei|Medical devices including metallic films and methods for making same|

US20060259131A1|2005-05-16|2006-11-16|Masoud Molaei|Medical devices including metallic films and methods for making same|

US20080171214A1|1999-11-19|2008-07-17|Advanced Bio Prosthetic Surfaces, Ltd.|High strength vacuum deposited nitinol alloy films and method of making same|

US20080243234A1|2007-03-27|2008-10-02|Medtronic Vascular, Inc.|Magnesium Alloy Stent|

DE102007029672A1|2007-06-27|2009-01-02|Lzh Laserzentrum Hannover E.V.|Implant and method for its production|

US20090304772A1|2002-09-26|2009-12-10|Advanced Bio Prosthetic Surfaces, A Wholly Owned Subsidiary Of Palmaz Scientific, Inc.|Implantable materials having engineered surfaces and method of making same|

US7931683B2|2007-07-27|2011-04-26|Boston Scientific Scimed, Inc.|Articles having ceramic coated surfaces|

US7938855B2|2007-11-02|2011-05-10|Boston Scientific Scimed, Inc.|Deformable underlayer for stent|

US7942926B2|2007-07-11|2011-05-17|Boston Scientific Scimed, Inc.|Endoprosthesis coating|

US7976915B2|2007-05-23|2011-07-12|Boston Scientific Scimed, Inc.|Endoprosthesis with select ceramic morphology|

US7981150B2|2006-11-09|2011-07-19|Boston Scientific Scimed, Inc.|Endoprosthesis with coatings|

US7985252B2|2008-07-30|2011-07-26|Boston Scientific Scimed, Inc.|Bioerodible endoprosthesis|

US7998192B2|2008-05-09|2011-08-16|Boston Scientific Scimed, Inc.|Endoprostheses|

US8002823B2|2007-07-11|2011-08-23|Boston Scientific Scimed, Inc.|Endoprosthesis coating|

US8002821B2|2006-09-18|2011-08-23|Boston Scientific Scimed, Inc.|Bioerodible metallic ENDOPROSTHESES|

US8029554B2|2007-11-02|2011-10-04|Boston Scientific Scimed, Inc.|Stent with embedded material|

US8048150B2|2006-04-12|2011-11-01|Boston Scientific Scimed, Inc.|Endoprosthesis having a fiber meshwork disposed thereon|

US8052745B2|2007-09-13|2011-11-08|Boston Scientific Scimed, Inc.|Endoprosthesis|

US8052744B2|2006-09-15|2011-11-08|Boston Scientific Scimed, Inc.|Medical devices and methods of making the same|

US8052743B2|2006-08-02|2011-11-08|Boston Scientific Scimed, Inc.|Endoprosthesis with three-dimensional disintegration control|

US8057534B2|2006-09-15|2011-11-15|Boston Scientific Scimed, Inc.|Bioerodible endoprostheses and methods of making the same|

US8067054B2|2007-04-05|2011-11-29|Boston Scientific Scimed, Inc.|Stents with ceramic drug reservoir layer and methods of making and using the same|

US8066763B2|1998-04-11|2011-11-29|Boston Scientific Scimed, Inc.|Drug-releasing stent with ceramic-containing layer|

US8071156B2|2009-03-04|2011-12-06|Boston Scientific Scimed, Inc.|Endoprostheses|

US8070797B2|2007-03-01|2011-12-06|Boston Scientific Scimed, Inc.|Medical device with a porous surface for delivery of a therapeutic agent|

US8080055B2|2006-12-28|2011-12-20|Boston Scientific Scimed, Inc.|Bioerodible endoprostheses and methods of making the same|

US8089029B2|2006-02-01|2012-01-03|Boston Scientific Scimed, Inc.|Bioabsorbable metal medical device and method of manufacture|

US8128689B2|2006-09-15|2012-03-06|Boston Scientific Scimed, Inc.|Bioerodible endoprosthesis with biostable inorganic layers|

US8187620B2|2006-03-27|2012-05-29|Boston Scientific Scimed, Inc.|Medical devices comprising a porous metal oxide or metal material and a polymer coating for delivering therapeutic agents|

US8216632B2|2007-11-02|2012-07-10|Boston Scientific Scimed, Inc.|Endoprosthesis coating|

US8221822B2|2007-07-31|2012-07-17|Boston Scientific Scimed, Inc.|Medical device coating by laser cladding|

US8231980B2|2008-12-03|2012-07-31|Boston Scientific Scimed, Inc.|Medical implants including iridium oxide|

US8236046B2|2008-06-10|2012-08-07|Boston Scientific Scimed, Inc.|Bioerodible endoprosthesis|

US8267992B2|2009-03-02|2012-09-18|Boston Scientific Scimed, Inc.|Self-buffering medical implants|

US8287937B2|2009-04-24|2012-10-16|Boston Scientific Scimed, Inc.|Endoprosthese|

US8303643B2|2001-06-27|2012-11-06|Remon Medical Technologies Ltd.|Method and device for electrochemical formation of therapeutic species in vivo|

US20130004469A1|2010-03-15|2013-01-03|Indiana University Research And Technology Corporation|Engineered lumenized vascular networks and support matrix|

US8348990B2|2002-11-25|2013-01-08|Advanced Bio Prosthetic Surfaces, Ltd.|Implantable expandable medical devices having regions of differential mechanical properties and methods of making same|

US8353949B2|2006-09-14|2013-01-15|Boston Scientific Scimed, Inc.|Medical devices with drug-eluting coating|

US8382824B2|2008-10-03|2013-02-26|Boston Scientific Scimed, Inc.|Medical implant having NANO-crystal grains with barrier layers of metal nitrides or fluorides|

US8431149B2|2007-03-01|2013-04-30|Boston Scientific Scimed, Inc.|Coated medical devices for abluminal drug delivery|

US8449603B2|2008-06-18|2013-05-28|Boston Scientific Scimed, Inc.|Endoprosthesis coating|

US8458879B2|2001-07-03|2013-06-11|Advanced Bio Prosthetic Surfaces, Ltd., A Wholly Owned Subsidiary Of Palmaz Scientific, Inc.|Method of fabricating an implantable medical device|

US8574615B2|2006-03-24|2013-11-05|Boston Scientific Scimed, Inc.|Medical devices having nanoporous coatings for controlled therapeutic agent delivery|

US8632583B2|2011-05-09|2014-01-21|Palmaz Scientific, Inc.|Implantable medical device having enhanced endothelial migration features and methods of making the same|

US8668732B2|2010-03-23|2014-03-11|Boston Scientific Scimed, Inc.|Surface treated bioerodible metal endoprostheses|

US8679517B2|2002-09-26|2014-03-25|Palmaz Scientific, Inc.|Implantable materials having engineered surfaces made by vacuum deposition and method of making same|

US8728563B2|2011-05-03|2014-05-20|Palmaz Scientific, Inc.|Endoluminal implantable surfaces, stents, and grafts and method of making same|

US8771343B2|2006-06-29|2014-07-08|Boston Scientific Scimed, Inc.|Medical devices with selective titanium oxide coatings|

US8808726B2|2006-09-15|2014-08-19|Boston Scientific Scimed. Inc.|Bioerodible endoprostheses and methods of making the same|

US8815273B2|2007-07-27|2014-08-26|Boston Scientific Scimed, Inc.|Drug eluting medical devices having porous layers|

US8815275B2|2006-06-28|2014-08-26|Boston Scientific Scimed, Inc.|Coatings for medical devices comprising a therapeutic agent and a metallic material|

US8840660B2|2006-01-05|2014-09-23|Boston Scientific Scimed, Inc.|Bioerodible endoprostheses and methods of making the same|

US8900292B2|2007-08-03|2014-12-02|Boston Scientific Scimed, Inc.|Coating for medical device having increased surface area|

US8920491B2|2008-04-22|2014-12-30|Boston Scientific Scimed, Inc.|Medical devices having a coating of inorganic material|

US8932346B2|2008-04-24|2015-01-13|Boston Scientific Scimed, Inc.|Medical devices having inorganic particle layers|

US8998977B2|2012-04-13|2015-04-07|Medtronic Vascular, Inc.|Hollow drug-filled stent and method of forming hollow drug-filled stent|

US9284409B2|2007-07-19|2016-03-15|Boston Scientific Scimed, Inc.|Endoprosthesis having a non-fouling surface|DE1452370C3|1965-06-26|1974-03-21|Hans Georg 6331 Hermannstein Forrer|Process for the production of small cross-section tubes|

DE3133871A1|1981-08-27|1983-03-10|M.A.N. Maschinenfabrik Augsburg-Nürnberg AG, 8000 München|METHOD FOR PRODUCING HOMOGENOUS COATINGS FROM TWO OR MORE METALS AND / OR METAL COMPOUNDS|

US4444848A|1982-01-04|1984-04-24|Western Electric Co., Inc.|Adherent metal coatings on rubber-modified epoxy resin surfaces|

US5190546A|1983-10-14|1993-03-02|Raychem Corporation|Medical devices incorporating SIM alloy elements|

US4665906A|1983-10-14|1987-05-19|Raychem Corporation|Medical devices incorporating sim alloy elements|

US5387247A|1983-10-25|1995-02-07|Sorin Biomedia S.P.A.|Prosthetic device having a biocompatible carbon film thereon and a method of and apparatus for forming such device|

US4582559A|1984-04-27|1986-04-15|Gould Inc.|Method of making thin free standing single crystal films|

US5084151A|1985-11-26|1992-01-28|Sorin Biomedica S.P.A.|Method and apparatus for forming prosthetic device having a biocompatible carbon film thereon|

JPH0536229B2|1985-12-28|1993-05-28|Kagaku Gijutsucho Koku Uchu Gijutsu Kenkyushocho||

US4846834A|1986-05-27|1989-07-11|Clemson University|Method for promoting tissue adhesion to soft tissue implants|

IT1196836B|1986-12-12|1988-11-25|Sorin Biomedica Spa|Polymeric or metal alloy prosthesis with biocompatible carbon coating|

US5133845A|1986-12-12|1992-07-28|Sorin Biomedica, S.P.A.|Method for making prosthesis of polymeric material coated with biocompatible carbon|

JPH0577329B2|1988-06-10|1993-10-26|Fujitsu Ltd||

GB8912498D0|1989-05-31|1989-07-19|De Beers Ind Diamond|Diamond growth|

US5061914A|1989-06-27|1991-10-29|Tini Alloy Company|Shape-memory alloy micro-actuator|

US5588443A|1989-07-25|1996-12-31|Smith & Nephew Richards, Inc.|Zirconium oxide and zirconium nitride coated guide wires|

US5477864A|1989-12-21|1995-12-26|Smith & Nephew Richards, Inc.|Cardiovascular guidewire of enhanced biocompatibility|

CA2034440A1|1990-02-13|1991-08-14|Thomas R. Anthony|Cvd diamond workpieces and their fabrication|

US5158750A|1990-06-06|1992-10-27|Praxair S.T. Technology, Inc.|Boron nitride crucible|

US5242710A|1990-06-25|1993-09-07|Lanxide Technology Company, Lp|Methods for making self-supporting composite bodies and articles produced thereby|

US5855955A|1995-06-07|1999-01-05|Lanxide Technology Company L.P.|Method for making self-supporting composite bodies|

US6113982A|1990-06-25|2000-09-05|Lanxide Technology Company, Lp|Composite bodies and methods for making same|

IL98530A|1990-06-25|1996-06-18|Lanxide Technology Co Ltd|Methods for making selfsupporting composite bodies and articles produced thereby using vapor-phase parent metals and solid oxidants|

KR950009939B1|1990-11-30|1995-09-01|가부시끼가이샤 히다찌세이사꾸쇼|Thin film forming method and semiconductor device thereby|

EP0491503A3|1990-12-19|1992-07-22|AT&T Corp.|Method for depositing metal|

US5179993A|1991-03-26|1993-01-19|Hughes Aircraft Company|Method of fabricating anisometric metal needles and birefringent suspension thereof in dielectric fluid|

JP2981804B2|1991-07-31|1999-11-22|キヤノン株式会社|Information processing apparatus, electrode substrate used therein, and information recording medium|

CA2380683C|1991-10-28|2006-08-08|Advanced Cardiovascular Systems, Inc.|Expandable stents and method for making same|

US5316023A|1992-01-08|1994-05-31|Expandable Grafts Partnership|Method for bilateral intra-aortic bypass|

US5685961A|1992-03-27|1997-11-11|P & D Medical Coatings, Inc.|Method for fabrication of metallized medical devices|

US5681575A|1992-05-19|1997-10-28|Westaim Technologies Inc.|Anti-microbial coating for medical devices|

US5510088A|1992-06-11|1996-04-23|The United States Of America As Represented By The Secretary Of The Navy|Low temperature plasma film deposition using dielectric chamber as source material|

US5342387A|1992-06-18|1994-08-30|American Biomed, Inc.|Artificial support for a blood vessel|

US5382261A|1992-09-01|1995-01-17|Expandable Grafts Partnership|Method and apparatus for occluding vessels|

US5630840A|1993-01-19|1997-05-20|Schneider Inc|Clad composite stent|

US5607463A|1993-03-30|1997-03-04|Medtronic, Inc.|Intravascular medical device|

US5358615A|1993-10-04|1994-10-25|Motorola, Inc.|Process for forming a sputter deposited metal film|

JP2703510B2|1993-12-28|1998-01-26|アドヴァンスドカーディオヴァスキュラーシステムズインコーポレーテッド|Expandable stent and method of manufacturing the same|

SI0821920T2|1994-02-25|2006-08-31|Fischell Robert|Stent|

US5798042A|1994-03-07|1998-08-25|Regents Of The University Of California|Microfabricated filter with specially constructed channel walls, and containment well and capsule constructed with such filters|

US5843120A|1994-03-17|1998-12-01|Medinol Ltd.|Flexible-expandable stent|

US6464722B2|1994-03-17|2002-10-15|Medinol, Ltd.|Flexible expandable stent|

US5733303A|1994-03-17|1998-03-31|Medinol Ltd.|Flexible expandable stent|

ES2162876T3|1994-03-24|2002-01-16|Canon Kk|COMMUNICATION DEVICE.|

US5725573A|1994-03-29|1998-03-10|Southwest Research Institute|Medical implants made of metal alloys bearing cohesive diamond like carbon coatings|

US5605714A|1994-03-29|1997-02-25|Southwest Research Institute|Treatments to reduce thrombogeneticity in heart valves made from titanium and its alloys|

US6165210A|1994-04-01|2000-12-26|Gore Enterprise Holdings, Inc.|Self-expandable helical intravascular stent and stent-graft|

TW289900B|1994-04-22|1996-11-01|Gould Electronics Inc||

CA2147709C|1994-04-25|1999-08-24|Sharon S. Lam|Radiopaque stent markers|

US5765418A|1994-05-16|1998-06-16|Medtronic, Inc.|Method for making an implantable medical device from a refractory metal|

US5984905A|1994-07-11|1999-11-16|Southwest Research Institute|Non-irritating antimicrobial coating for medical implants and a process for preparing same|

DE4429380C1|1994-08-15|1996-04-25|Biotronik Mess & Therapieg|Method for producing a non-collapsing intravascular vascular prosthesis |

US6015429A|1994-09-08|2000-01-18|Gore Enterprise Holdings, Inc.|Procedures for introducing stents and stent-grafts|

US5545210A|1994-09-22|1996-08-13|Advanced Coronary Technology, Inc.|Method of implanting a permanent shape memory alloy stent|

US5482574A|1994-10-04|1996-01-09|The United States Of America As Represented By The Secretary Of The Navy|Method of making composite structure having a porous shape-memory component|

US5590854A|1994-11-02|1997-01-07|Shatz; Solomon|Movable sheet for laminar flow and deicing|

CA2163824C|1994-11-28|2000-06-20|Richard J. Saunders|Method and apparatus for direct laser cutting of metal stents|

JP3577353B2|1995-01-27|2004-10-13|テルモ株式会社|In-vivo stent|

US6120536A|1995-04-19|2000-09-19|Schneider Inc.|Medical devices with long term non-thrombogenic coatings|

US5508116A|1995-04-28|1996-04-16|The United States Of America As Represented By The Secretary Of The Navy|Metal matrix composite reinforced with shape memory alloy|

US5624508A|1995-05-02|1997-04-29|Flomenblit; Josef|Manufacture of a two-way shape memory alloy and device|

US5631203A|1995-05-04|1997-05-20|Phillips Petroleum Company|Metallocene compounds and preparation thereof containing terminal alkynes|

US6059810A|1995-05-10|2000-05-09|Scimed Life Systems, Inc.|Endovascular stent and method|

WO1996037165A1|1995-05-26|1996-11-28|Bsi Corporation|Method and implantable article for promoting endothelialization|

US5578149A|1995-05-31|1996-11-26|Global Therapeutics, Inc.|Radially expandable stent|

US5593442A|1995-06-05|1997-01-14|Localmed, Inc.|Radially expansible and articulated vessel scaffold|

US5609629A|1995-06-07|1997-03-11|Med Institute, Inc.|Coated implantable medical device|

CA2178541C|1995-06-07|2009-11-24|Neal E. Fearnot|Implantable medical device|

US5597458A|1995-07-10|1997-01-28|Advanced Micro Devices|Method for producing alloy films using cold sputter deposition process|

GB9516927D0|1995-08-18|1995-10-18|Secr Defence|Preparation of structural materials by nanoscale laminar pvd process|

US5607475A|1995-08-22|1997-03-04|Medtronic, Inc.|Biocompatible medical article and method|

US5776161A|1995-10-16|1998-07-07|Instent, Inc.|Medical stents, apparatus and method for making same|

US6126793A|1995-10-17|2000-10-03|Citizen Watch Co., Ltd.|Method of forming films over inner surface of cylindrical member|

US5744958A|1995-11-07|1998-04-28|Iti Medical Technologies, Inc.|Instrument having ultra-thin conductive coating and method for magnetic resonance imaging of such instrument|

US5628788A|1995-11-07|1997-05-13|Corvita Corporation|Self-expanding endoluminal stent-graft|

US5788558A|1995-11-13|1998-08-04|Localmed, Inc.|Apparatus and method for polishing lumenal prostheses|

US5913896A|1995-11-28|1999-06-22|Medtronic, Inc.|Interwoven dual sinusoidal helix stent|

US5840009A|1995-12-05|1998-11-24|Isostent, Inc.|Radioisotope stent with increased radiation field strength at the ends of the stent|

US5723219A|1995-12-19|1998-03-03|Talison Research|Plasma deposited film networks|

US5843289A|1996-01-22|1998-12-01|Etex Corporation|Surface modification of medical implants|

US6033582A|1996-01-22|2000-03-07|Etex Corporation|Surface modification of medical implants|

US5938682A|1996-01-26|1999-08-17|Cordis Corporation|Axially flexible stent|

US5895406A|1996-01-26|1999-04-20|Cordis Corporation|Axially flexible stent|

WO1997027959A1|1996-01-30|1997-08-07|Medtronic, Inc.|Articles for and methods of making stents|

US5843117A|1996-02-14|1998-12-01|Inflow Dynamics Inc.|Implantable vascular and endoluminal stents and process of fabricating the same|

US5772864A|1996-02-23|1998-06-30|Meadox Medicals, Inc.|Method for manufacturing implantable medical devices|

JP2899682B2|1996-03-22|1999-06-02|科学技術庁金属材料技術研究所長|Ti-Ni based shape memory alloy and method for producing the same|

CA2199890C|1996-03-26|2002-02-05|Leonard Pinchuk|Stents and stent-grafts having enhanced hoop strength and methods of making the same|

US6019784A|1996-04-04|2000-02-01|Electroformed Stents, Inc.|Process for making electroformed stents|

NZ331269A|1996-04-10|2000-01-28|Advanced Cardiovascular System|Expandable stent, its structural strength varying along its length|

FR2747301B1|1996-04-10|1998-09-18|Nycomed Lab Sa|IMPLANTABLE DEVICE FOR MAINTAINING OR RE-ESTABLISHING THE NORMAL PASSAGE SECTION OF A BODY DUCT, AS WELL AS A SYSTEM FOR ITS PLACEMENT|

US5932299A|1996-04-23|1999-08-03|Katoot; Mohammad W.|Method for modifying the surface of an object|

US5855802A|1996-05-30|1999-01-05|International Business Machines Corporation|Method and apparatus for forming a tubular article having a perforated annular wall|

US5811151A|1996-05-31|1998-09-22|Medtronic, Inc.|Method of modifying the surface of a medical device|

US5769884A|1996-06-27|1998-06-23|Cordis Corporation|Controlled porosity endovascular implant|

US5951881A|1996-07-22|1999-09-14|President And Fellows Of Harvard College|Fabrication of small-scale cylindrical articles|

RU2110606C1|1996-07-25|1998-05-10|Беграмбеков Леон Богданович|Device for deposition of surface layers on articles by method of treatment with gas-discharge plasma|

US5728150A|1996-07-29|1998-03-17|Cardiovascular Dynamics, Inc.|Expandable microporous prosthesis|

US6261320B1|1996-11-21|2001-07-17|Radiance Medical Systems, Inc.|Radioactive vascular liner|

US6013855A|1996-08-06|2000-01-11|United States Surgical|Grafting of biocompatible hydrophilic polymers onto inorganic and metal surfaces|

US6007573A|1996-09-18|1999-12-28|Microtherapeutics, Inc.|Intracranial stent and method of use|

WO1998014137A1|1996-10-01|1998-04-09|Numed, Inc.|Expandable stent|

US5824045A|1996-10-21|1998-10-20|Inflow Dynamics Inc.|Vascular and endoluminal stents|

US5836964A|1996-10-30|1998-11-17|Medinol Ltd.|Stent fabrication method|

US6197013B1|1996-11-06|2001-03-06|Setagon, Inc.|Method and apparatus for drug and gene delivery|

ZA9710342B|1996-11-25|1998-06-10|Alza Corp|Directional drug delivery stent and method of use.|

DE19653720A1|1996-12-10|1998-06-18|Biotronik Mess & Therapieg|Stent|

US5868782A|1996-12-24|1999-02-09|Global Therapeutics, Inc.|Radially expandable axially non-contracting surgical stent|

US5906759A|1996-12-26|1999-05-25|Medinol Ltd.|Stent forming apparatus with stent deforming blades|

IT1289815B1|1996-12-30|1998-10-16|Sorin Biomedica Cardio Spa|ANGIOPLASTIC STENT AND RELATED PRODUCTION PROCESS|

US5776162A|1997-01-03|1998-07-07|Nitinol Medical Technologies, Inc.|Vessel implantable shape memory appliance with superelastic hinged joint|

US5858556A|1997-01-21|1999-01-12|Uti Corporation|Multilayer composite tubular structure and method of making|

US5853419A|1997-03-17|1998-12-29|Surface Genesis, Inc.|Stent|

US5954724A|1997-03-27|1999-09-21|Davidson; James A.|Titanium molybdenum hafnium alloys for medical implants and devices|

US6240616B1|1997-04-15|2001-06-05|Advanced Cardiovascular Systems, Inc.|Method of manufacturing a medicated porous metal prosthesis|

US6033433A|1997-04-25|2000-03-07|Scimed Life Systems, Inc.|Stent configurations including spirals|

US6013054A|1997-04-28|2000-01-11|Advanced Cardiovascular Systems, Inc.|Multifurcated balloon catheter|

US5741327A|1997-05-06|1998-04-21|Global Therapeutics, Inc.|Surgical stent featuring radiopaque markers|

US6173672B1|1997-06-06|2001-01-16|Celestech, Inc.|Diamond film deposition on substrate arrays|

US5891507A|1997-07-28|1999-04-06|Iowa-India Investments Company Limited|Process for coating a surface of a metallic stent|

US5855600A|1997-08-01|1999-01-05|Inflow Dynamics Inc.|Flexible implantable stent with composite design|

US5899935A|1997-08-04|1999-05-04|Schneider Inc.|Balloon expandable braided stent with restraint|

US5897911A|1997-08-11|1999-04-27|Advanced Cardiovascular Systems, Inc.|Polymer-coated stent structure|

US5925063A|1997-09-26|1999-07-20|Khosravi; Farhad|Coiled sheet valve, filter or occlusive device and methods of use|

US5972027A|1997-09-30|1999-10-26|Scimed Life Systems, Inc|Porous stent drug delivery system|

WO1999018265A2|1997-10-08|1999-04-15|The Regents Of The University Of California|Aqueous electrodeposition of rare earth and transition metals|

US6309414B1|1997-11-04|2001-10-30|Sorin Biomedica Cardio S.P.A.|Angioplasty stents|

DE69830605T3|1997-11-07|2012-02-09|Expandable Grafts Partnership|INTRAVASCULAR STENT AND MANUFACTURING METHOD THEREFOR|

GB2336376B|1997-11-12|2002-10-30|Daido Steelco Ltd|Intermetallic-compound coated stainless steel and method of producing the same|

NO311781B1|1997-11-13|2002-01-28|Medinol Ltd|Metal multilayer stents|

US6267782B1|1997-11-20|2001-07-31|St. Jude Medical, Inc.|Medical article with adhered antimicrobial metal|

US5955588A|1997-12-22|1999-09-21|Innerdyne, Inc.|Non-thrombogenic coating composition and methods for using same|

US6016693A|1998-02-09|2000-01-25|The Regents Of The University Of California|Microfabrication of cantilevers using sacrificial templates|

AU2867499A|1998-02-10|1999-08-23|Implant Sciences Corporation|Soft x-ray emitting medical devices|

US6106642A|1998-02-19|2000-08-22|Boston Scientific Limited|Process for the improved ductility of nitinol|

US6284316B1|1998-02-25|2001-09-04|Micron Technology, Inc.|Chemical vapor deposition of titanium|

US5938697A|1998-03-04|1999-08-17|Scimed Life Systems, Inc.|Stent having variable properties|

JP2002505382A|1998-03-05|2002-02-19|メムリー・コーポレイション|Pseudoelastic beta titanium alloy and its use|

US6103320A|1998-03-05|2000-08-15|Shincron Co., Ltd.|Method for forming a thin film of a metal compound by vacuum deposition|

JP3735461B2|1998-03-27|2006-01-18|株式会社シンクロン|Compound metal compound thin film forming method and thin film forming apparatus therefor|

US6264687B1|1998-04-20|2001-07-24|Cordis Corporation|Multi-laminate stent having superelastic articulated sections|

FR2777771B1|1998-04-27|2000-08-25|Microval|TUBULAR AND FLEXIBLE VASCULAR ENDOPROSTHESIS|

US6086773A|1998-05-22|2000-07-11|Bmc Industries, Inc.|Method and apparatus for etching-manufacture of cylindrical elements|

US6267867B1|1998-05-26|2001-07-31|Saint-Gobain Industrial Ceramics, Inc.|Composite article with adherent CVD diamond coating and method of making|

US6149742A|1998-05-26|2000-11-21|Lockheed Martin Corporation|Process for conditioning shape memory alloys|

US6066169A|1998-06-02|2000-05-23|Ave Connaught|Expandable stent having articulated connecting rods|

AU756080B2|1998-06-04|2003-01-02|New York University|Endovascular thin film devices and methods for treating and preventing stroke|

US6203505B1|1998-06-05|2001-03-20|Advanced Cardiovascular Systems, Inc.|Guidewires having a vapor deposited primer coat|

US6126761A|1998-06-10|2000-10-03|International Business Machines Corporation|Process of controlling grain growth in metal films|

US6203732B1|1998-07-02|2001-03-20|Intra Therapeutics, Inc.|Method for manufacturing intraluminal device|

JP2000017457A|1998-07-03|2000-01-18|Shincron:Kk|Thin film forming apparatus and thin film forming method|

US6096175A|1998-07-17|2000-08-01|Micro Therapeutics, Inc.|Thin film stent|

US6264598B1|1998-08-06|2001-07-24|Implant Sciences Corporation|Palladium coated implant|

US6231923B1|1998-08-17|2001-05-15|Tevtech Llc|Chemical vapor deposition of near net shape monolithic ceramic parts|

EP1105169A1|1998-08-20|2001-06-13|Cook Incorporated|Coated implantable medical device|

US6042597A|1998-10-23|2000-03-28|Scimed Life Systems, Inc.|Helical stent design|

US6325820B1|1998-11-16|2001-12-04|Endotex Interventional Systems, Inc.|Coiled-sheet stent-graft with exo-skeleton|

US6258417B1|1998-11-24|2001-07-10|Research Foundation Of State University Of New York|Method of producing nanocomposite coatings|

US6232150B1|1998-12-03|2001-05-15|The Regents Of The University Of Michigan|Process for making microstructures and microstructures made thereby|

US6234981B1|1998-12-30|2001-05-22|Advanced Cardiovascular Systems, Inc.|Vapor deposition coated intracorporeal device|

US6120847A|1999-01-08|2000-09-19|Scimed Life Systems, Inc.|Surface treatment method for stent coating|

US6264595B1|1999-02-04|2001-07-24|Mobeta, Inc.|Radioactive transition metal stents|

US6245104B1|1999-02-28|2001-06-12|Inflow Dynamics Inc.|Method of fabricating a biocompatible stent|

JP4351755B2|1999-03-12|2009-10-28|キヤノンアネルバ株式会社|Thin film forming method and thin film forming apparatus|

US6253441B1|1999-04-16|2001-07-03|General Electric Company|Fabrication of articles having a coating deposited through a mask|

US6273911B1|1999-04-22|2001-08-14|Advanced Cardiovascular Systems, Inc.|Variable strength stent|

US6156373A|1999-05-03|2000-12-05|Scimed Life Systems, Inc.|Medical device coating methods and devices|

US6238491B1|1999-05-05|2001-05-29|Davitech, Inc.|Niobium-titanium-zirconium-molybdenum alloys for dental and other medical device applications|

US6258121B1|1999-07-02|2001-07-10|Scimed Life Systems, Inc.|Stent coating|

DE19937638B4|1999-08-12|2006-11-02|Alveolus Inc.|Tracheal Stent|

US6322588B1|1999-08-17|2001-11-27|St. Jude Medical, Inc.|Medical devices with metal/polymer composites|

US20010047200A1|1999-10-13|2001-11-29|Raymond Sun|Non-foreshortening intraluminal prosthesis|

US6428569B1|1999-11-09|2002-08-06|Scimed Life Systems Inc.|Micro structure stent configurations|

US7235092B2|1999-11-19|2007-06-26|Advanced Bio Prosthetic Surfaces, Ltd.|Guidewires and thin film catheter-sheaths and method of making same|

US6849085B2|1999-11-19|2005-02-01|Advanced Bio Prosthetic Surfaces, Ltd.|Self-supporting laminated films, structural materials and medical devices manufactured therefrom and method of making same|

AU3109901A|2000-01-24|2001-07-31|Smart Therapeutics Inc|Thin-film shape memory alloy device and method|

WO2001055473A1|2000-01-25|2001-08-02|Boston Scientific Limited|Manufacturing medical devices by vapor deposition|

US6312463B1|2000-02-01|2001-11-06|Endotex Interventional Systems, Inc.|Micro-porous mesh stent with hybrid structure|

US6509067B2|2000-04-28|2003-01-21|Jet Process Corporation|Method and apparatus for the deposition of metal nanoclusters and films on a substrate|

JP2002020863A|2000-05-01|2002-01-23|Canon Inc|Method and system for forming deposit film, and method for treating substrate|

DE10050971A1|2000-10-10|2002-04-11|Biotronik Mess & Therapieg|stent|US6006134A|1998-04-30|1999-12-21|Medtronic, Inc.|Method and device for electronically controlling the beating of a heart using venous electrical stimulation of nerve fibers|

US7749245B2|2000-01-27|2010-07-06|Medtronic, Inc.|Cardiac valve procedure methods and devices|

JP3555844B2|1999-04-09|2004-08-18|三宅正二郎|Sliding member and manufacturing method thereof|

US8016877B2|1999-11-17|2011-09-13|Medtronic Corevalve Llc|Prosthetic valve for transluminal delivery|

US7018406B2|1999-11-17|2006-03-28|Corevalve Sa|Prosthetic valve for transluminal delivery|

US8579966B2|1999-11-17|2013-11-12|Medtronic Corevalve Llc|Prosthetic valve for transluminal delivery|

US7235092B2|1999-11-19|2007-06-26|Advanced Bio Prosthetic Surfaces, Ltd.|Guidewires and thin film catheter-sheaths and method of making same|

US6537310B1|1999-11-19|2003-03-25|Advanced Bio Prosthetic Surfaces, Ltd.|Endoluminal implantable devices and method of making same|

US8845713B2|2000-05-12|2014-09-30|Advanced Bio Prosthetic Surfaces, Ltd., A Wholly Owned Subsidiary Of Palmaz Scientific, Inc.|Self-supporting laminated films, structural materials and medical devices manufactured therefrom and methods of making same|

US6936066B2|1999-11-19|2005-08-30|Advanced Bio Prosthetic Surfaces, Ltd.|Complaint implantable medical devices and methods of making same|

US10172730B2|1999-11-19|2019-01-08|Vactronix Scientific, Llc|Stents with metallic covers and methods of making same|

US8241274B2|2000-01-19|2012-08-14|Medtronic, Inc.|Method for guiding a medical device|

AU3109901A|2000-01-24|2001-07-31|Smart Therapeutics Inc|Thin-film shape memory alloy device and method|

WO2001055473A1|2000-01-25|2001-08-02|Boston Scientific Limited|Manufacturing medical devices by vapor deposition|

US7544206B2|2001-06-29|2009-06-09|Medtronic, Inc.|Method and apparatus for resecting and replacing an aortic valve|

US8771302B2|2001-06-29|2014-07-08|Medtronic, Inc.|Method and apparatus for resecting and replacing an aortic valve|

US8623077B2|2001-06-29|2014-01-07|Medtronic, Inc.|Apparatus for replacing a cardiac valve|

AU7308801A|2000-06-30|2002-01-30|Viacor Inc|Intravascular filter with debris entrapment mechanism|

US20020022860A1|2000-08-18|2002-02-21|Borillo Thomas E.|Expandable implant devices for filtering blood flow from atrial appendages|

US7097659B2|2001-09-07|2006-08-29|Medtronic, Inc.|Fixation band for affixing a prosthetic heart valve to tissue|

AU3393602A|2000-11-07|2002-05-21|Advanced Bio Prosthetic Surfac|Endoluminal stent, self-fupporting endoluminal graft and methods of making same|

US8252044B1|2000-11-17|2012-08-28|Advanced Bio Prosthestic Surfaces, Ltd.|Device for in vivo delivery of bioactive agents and method of manufacture thereof|

JP2005506112A|2001-04-26|2005-03-03|バスキュラーイノベイション，インコーポレイティド|Intraluminal device and method of making the same|

FR2826863B1|2001-07-04|2003-09-26|Jacques Seguin|ASSEMBLY FOR THE PLACEMENT OF A PROSTHETIC VALVE IN A BODY CONDUIT|

FR2828091B1|2001-07-31|2003-11-21|Seguin Jacques|ASSEMBLY ALLOWING THE PLACEMENT OF A PROTHETIC VALVE IN A BODY DUCT|

US8562664B2|2001-10-25|2013-10-22|Advanced Cardiovascular Systems, Inc.|Manufacture of fine-grained material for use in medical devices|

GB0130608D0|2001-12-21|2002-02-06|Psimedica Ltd|Medical fibres and fabrics|

US20030181972A1|2002-03-22|2003-09-25|Scimed Life Systems, Inc.|MRI and x-ray compatible stent material|

US8721713B2|2002-04-23|2014-05-13|Medtronic, Inc.|System for implanting a replacement valve|

US6865810B2|2002-06-27|2005-03-15|Scimed Life Systems, Inc.|Methods of making medical devices|

JP4995420B2|2002-09-26|2012-08-08|アドヴァンスドバイオプロスセティックサーフェシーズリミテッド|High strength vacuum deposited Nitinol alloy film, medical thin film graft material, and method of making same.|

US6969198B2|2002-11-06|2005-11-29|Nissan Motor Co., Ltd.|Low-friction sliding mechanism|

EP1482190B1|2003-05-27|2012-12-05|Nissan Motor Company Limited|Rolling element|

US8999364B2|2004-06-15|2015-04-07|Nanyang Technological University|Implantable article, method of forming same and method for reducing thrombogenicity|

JP4863152B2|2003-07-31|2012-01-25|日産自動車株式会社|gear|

KR101003865B1|2003-08-06|2010-12-30|닛산 지도우샤 가부시키가이샤|Low-Friction Sliding Mechanism, Low-Friction Agent Composition and Method of Friction Reduction|

JP2005054617A|2003-08-08|2005-03-03|Nissan Motor Co Ltd|Valve system|

JP4973971B2|2003-08-08|2012-07-11|日産自動車株式会社|Sliding member|

US7771821B2|2003-08-21|2010-08-10|Nissan Motor Co., Ltd.|Low-friction sliding member and low-friction sliding mechanism using same|

EP1508611B1|2003-08-22|2019-04-17|Nissan Motor Co., Ltd.|Transmission comprising low-friction sliding members and transmission oil therefor|

WO2005030091A2|2003-09-25|2005-04-07|Scios Inc.|Stents and intra-luminal prostheses containing map kinase inhibitors|

US9579194B2|2003-10-06|2017-02-28|Medtronic ATS Medical, Inc.|Anchoring structure with concave landing zone|

US7186265B2|2003-12-10|2007-03-06|Medtronic, Inc.|Prosthetic cardiac valves and systems and methods for implanting thereof|

US7959666B2|2003-12-23|2011-06-14|Sadra Medical, Inc.|Methods and apparatus for endovascularly replacing a heart valve|

US8343213B2|2003-12-23|2013-01-01|Sadra Medical, Inc.|Leaflet engagement elements and methods for use thereof|

US8840663B2|2003-12-23|2014-09-23|Sadra Medical, Inc.|Repositionable heart valve method|

US8052749B2|2003-12-23|2011-11-08|Sadra Medical, Inc.|Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements|

US9005273B2|2003-12-23|2015-04-14|Sadra Medical, Inc.|Assessing the location and performance of replacement heart valves|

US8603160B2|2003-12-23|2013-12-10|Sadra Medical, Inc.|Method of using a retrievable heart valve anchor with a sheath|

EP2529699B1|2003-12-23|2014-01-29|Sadra Medical, Inc.|Repositionable heart valve|

US7381219B2|2003-12-23|2008-06-03|Sadra Medical, Inc.|Low profile heart valve and delivery system|

US7329279B2|2003-12-23|2008-02-12|Sadra Medical, Inc.|Methods and apparatus for endovascularly replacing a patient's heart valve|

US9526609B2|2003-12-23|2016-12-27|Boston Scientific Scimed, Inc.|Methods and apparatus for endovascularly replacing a patient's heart valve|

US20050137694A1|2003-12-23|2005-06-23|Haug Ulrich R.|Methods and apparatus for endovascularly replacing a patient's heart valve|

US7748389B2|2003-12-23|2010-07-06|Sadra Medical, Inc.|Leaflet engagement elements and methods for use thereof|

US20050137691A1|2003-12-23|2005-06-23|Sadra Medical|Two piece heart valve and anchor|

US8182528B2|2003-12-23|2012-05-22|Sadra Medical, Inc.|Locking heart valve anchor|

US7824443B2|2003-12-23|2010-11-02|Sadra Medical, Inc.|Medical implant delivery and deployment tool|

US8579962B2|2003-12-23|2013-11-12|Sadra Medical, Inc.|Methods and apparatus for performing valvuloplasty|

US7824442B2|2003-12-23|2010-11-02|Sadra Medical, Inc.|Methods and apparatus for endovascularly replacing a heart valve|

US20120041550A1|2003-12-23|2012-02-16|Sadra Medical, Inc.|Methods and Apparatus for Endovascular Heart Valve Replacement Comprising Tissue Grasping Elements|

US7988724B2|2003-12-23|2011-08-02|Sadra Medical, Inc.|Systems and methods for delivering a medical implant|

US7445631B2|2003-12-23|2008-11-04|Sadra Medical, Inc.|Methods and apparatus for endovascularly replacing a patient's heart valve|

US20050137696A1|2003-12-23|2005-06-23|Sadra Medical|Apparatus and methods for protecting against embolization during endovascular heart valve replacement|

US20050288773A1|2004-01-22|2005-12-29|Glocker David A|Radiopaque coating for biomedical devices|

US20070106374A1|2004-01-22|2007-05-10|Isoflux, Inc.|Radiopaque coating for biomedical devices|

JP4838709B2|2004-03-30|2011-12-14|トーヨーエイテック株式会社|Substrate manufacturing method|

JP2007532185A|2004-04-05|2007-11-15|メディバスエルエルシー|Bioactive stent for type II diabetes and method of use thereof|

US7780725B2|2004-06-16|2010-08-24|Sadra Medical, Inc.|Everting heart valve|

US7585318B2|2004-06-18|2009-09-08|Boston Scientific Scimed, Inc.|Medical devices and methods of making the same|

EP1761212A4|2004-06-28|2009-09-09|Isoflux Inc|Porous coatings for biomedical implants|

US20060052867A1|2004-09-07|2006-03-09|Medtronic, Inc|Replacement prosthetic heart valve, system and method of implant|

US7344560B2|2004-10-08|2008-03-18|Boston Scientific Scimed, Inc.|Medical devices and methods of making the same|

US20060085065A1|2004-10-15|2006-04-20|Krause Arthur A|Stent with auxiliary treatment structure|

US8562672B2|2004-11-19|2013-10-22|Medtronic, Inc.|Apparatus for treatment of cardiac valves and method of its manufacture|

US7727273B2|2005-01-13|2010-06-01|Boston Scientific Scimed, Inc.|Medical devices and methods of making the same|

US8057543B2|2005-01-28|2011-11-15|Greatbatch Ltd.|Stent coating for eluting medication|

JP2008532643A|2005-03-09|2008-08-21|ザユニバーシティーオブテネシーリサーチファウンデーション|Barrier stent and use thereof|

US7962208B2|2005-04-25|2011-06-14|Cardiac Pacemakers, Inc.|Method and apparatus for pacing during revascularization|

US20060259126A1|2005-05-05|2006-11-16|Jason Lenz|Medical devices and methods of making the same|

US7914569B2|2005-05-13|2011-03-29|Medtronics Corevalve Llc|Heart valve prosthesis and methods of manufacture and use|

US8187327B2|2005-05-18|2012-05-29|Kyphon Sarl|Selectively-expandable bone scaffold|

US8273117B2|2005-06-22|2012-09-25|Integran Technologies Inc.|Low texture, quasi-isotropic metallic stent|

US7712606B2|2005-09-13|2010-05-11|Sadra Medical, Inc.|Two-part package for medical implant|

WO2007038540A1|2005-09-26|2007-04-05|Medtronic, Inc.|Prosthetic cardiac and venous valves|

US8287584B2|2005-11-14|2012-10-16|Sadra Medical, Inc.|Medical implant deployment tool|

US20070213813A1|2005-12-22|2007-09-13|Symetis Sa|Stent-valves for valve replacement and associated methods and systems for surgery|

US9078781B2|2006-01-11|2015-07-14|Medtronic, Inc.|Sterile cover for compressible stents used in percutaneous device delivery systems|

US7736687B2|2006-01-31|2010-06-15|Advance Bio Prosthetic Surfaces, Ltd.|Methods of making medical devices|

US20080299337A1|2006-02-09|2008-12-04|Isoflux, Inc.|Method for the formation of surfaces on the inside of medical devices|

US20070184257A1|2006-02-09|2007-08-09|Isoflux, Inc.|Formation of nanoscale surfaces for the atttachment of biological materials|

WO2007123658A1|2006-03-28|2007-11-01|Medtronic, Inc.|Prosthetic cardiac valve formed from pericardium material and methods of making same|

US20070239268A1|2006-03-30|2007-10-11|Lee Fox|Adhesion resistant implantable device|

US7740655B2|2006-04-06|2010-06-22|Medtronic Vascular, Inc.|Reinforced surgical conduit for implantation of a stented valve therein|

US7524331B2|2006-04-06|2009-04-28|Medtronic Vascular, Inc.|Catheter delivered valve having a barrier to provide an enhanced seal|

US20070239269A1|2006-04-07|2007-10-11|Medtronic Vascular, Inc.|Stented Valve Having Dull Struts|

US20070244544A1|2006-04-14|2007-10-18|Medtronic Vascular, Inc.|Seal for Enhanced Stented Valve Fixation|

US20070244545A1|2006-04-14|2007-10-18|Medtronic Vascular, Inc.|Prosthetic Conduit With Radiopaque Symmetry Indicators|

US20070244546A1|2006-04-18|2007-10-18|Medtronic Vascular, Inc.|Stent Foundation for Placement of a Stented Valve|

US7955383B2|2006-04-25|2011-06-07|Medtronics Vascular, Inc.|Laminated implantable medical device having a metallic coating|

US7691400B2|2006-05-05|2010-04-06|Medtronic Vascular, Inc.|Medical device having coating with zeolite drug reservoirs|

CA2550801C|2006-06-22|2010-07-20|Boart Longyear Inc.|Drilling equipment|

US7824438B2|2006-07-06|2010-11-02|Robert Kipperman|Method for placement of a stent assembly in a bifurcated vessel|

US8066753B2|2006-07-06|2011-11-29|Robert Kipperman|Specialized catheter and method for placement in a bifurcated vessel|

EP2076296A2|2006-09-15|2009-07-08|Boston Scientific Scimed, Inc.|Endoprosthesis with adjustable surface features|

US8052750B2|2006-09-19|2011-11-08|Medtronic Ventor Technologies Ltd|Valve prosthesis fixation techniques using sandwiching|

US8834564B2|2006-09-19|2014-09-16|Medtronic, Inc.|Sinus-engaging valve fixation member|

US20080090097A1|2006-10-11|2008-04-17|The Penn State Research Foundation|Chemically and physically tailored structured thin film assemblies for corrosion prevention or promotion|

US8784478B2|2006-10-16|2014-07-22|Medtronic Corevalve, Inc.|Transapical delivery system with ventruculo-arterial overlfow bypass|

EP2104470A2|2006-12-06|2009-09-30|Medtronic Corevalve, LLC.|System and method for transapical delivery of an annulus anchored self-expanding valve|

US8584767B2|2007-01-25|2013-11-19|Tini Alloy Company|Sprinkler valve with active actuation|

WO2008092028A1|2007-01-25|2008-07-31|Tini Alloy Company|Frangible shape memory alloy fire sprinkler valve actuator|

US7871436B2|2007-02-16|2011-01-18|Medtronic, Inc.|Replacement prosthetic heart valves and methods of implantation|

US20080206441A1|2007-02-27|2008-08-28|Medtronic Vascular, Inc.|Ion Beam Etching a Surface of an Implantable Medical Device|

US20080249597A1|2007-04-05|2008-10-09|Russell Scott M|Thin film tissue repair matrix|

FR2915087B1|2007-04-20|2021-11-26|Corevalve Inc|IMPLANT FOR TREATMENT OF A HEART VALVE, IN PARTICULAR OF A MITRAL VALVE, EQUIPMENT INCLUDING THIS IMPLANT AND MATERIAL FOR PLACING THIS IMPLANT.|

US8398702B2|2007-06-29|2013-03-19|Boston Scientific Scimed, Inc.|Molybdenum endoprostheses|

US7604662B2|2007-07-13|2009-10-20|Boston Scientific Scimed, Inc.|Endoprostheses containing boride intermetallic phases|

US8007674B2|2007-07-30|2011-08-30|Tini Alloy Company|Method and devices for preventing restenosis in cardiovascular stents|

US8747458B2|2007-08-20|2014-06-10|Medtronic Ventor Technologies Ltd.|Stent loading tool and method for use thereof|

EP2949292B8|2007-08-21|2016-06-15|Symetis Sa|Replacement valve|

US10856970B2|2007-10-10|2020-12-08|Medtronic Ventor Technologies Ltd.|Prosthetic heart valve for transfemoral delivery|

US9848981B2|2007-10-12|2017-12-26|Mayo Foundation For Medical Education And Research|Expandable valve prosthesis with sealing mechanism|

JP5603776B2|2007-10-25|2014-10-08|サイメティスエスアー|Stent, valved stent and method, and delivery system thereof|

US8118857B2|2007-11-29|2012-02-21|Boston Scientific Corporation|Medical articles that stimulate endothelial cell migration|

US9149358B2|2008-01-24|2015-10-06|Medtronic, Inc.|Delivery systems for prosthetic heart valves|

US8157852B2|2008-01-24|2012-04-17|Medtronic, Inc.|Delivery systems and methods of implantation for prosthetic heart valves|

US9089422B2|2008-01-24|2015-07-28|Medtronic, Inc.|Markers for prosthetic heart valves|

US9393115B2|2008-01-24|2016-07-19|Medtronic, Inc.|Delivery systems and methods of implantation for prosthetic heart valves|

CA2714062A1|2008-01-24|2009-07-30|Medtronic, Inc.|Stents for prosthetic heart valves|

BR112012021347A2|2008-02-26|2019-09-24|Jenavalve Tecnology Inc|stent for positioning and anchoring a valve prosthesis at an implantation site in a patient's heart|

US8313525B2|2008-03-18|2012-11-20|Medtronic Ventor Technologies, Ltd.|Valve suturing and implantation procedures|

US8430927B2|2008-04-08|2013-04-30|Medtronic, Inc.|Multiple orifice implantable heart valve and methods of implantation|

US20090287301A1|2008-05-16|2009-11-19|Boston Scientific, Scimed Inc.|Coating for medical implants|

US8840661B2|2008-05-16|2014-09-23|Sorin Group Italia S.R.L.|Atraumatic prosthetic heart valve prosthesis|

US8206636B2|2008-06-20|2012-06-26|Amaranth Medical Pte.|Stent fabrication via tubular casting processes|

US8206635B2|2008-06-20|2012-06-26|Amaranth Medical Pte.|Stent fabrication via tubular casting processes|

EP2307067A2|2008-06-25|2011-04-13|Boston Scientific Scimed, Inc.|Medical devices containing therapeutic agents|

US20100070022A1|2008-09-12|2010-03-18|Boston Scientific Scimed, Inc.|Layer by layer manufacturing of a stent|

WO2010031060A1|2008-09-15|2010-03-18|Medtronic Ventor Technologies Ltd.|Prosthetic heart valve having identifiers for aiding in radiographic positioning|

US8721714B2|2008-09-17|2014-05-13|Medtronic Corevalve Llc|Delivery system for deployment of medical devices|

EP3238661B1|2008-10-10|2019-05-22|Boston Scientific Scimed, Inc.|Medical devices and delivery systems for delivering medical devices|

US8137398B2|2008-10-13|2012-03-20|Medtronic Ventor Technologies Ltd|Prosthetic valve having tapered tip when compressed for delivery|

US8986361B2|2008-10-17|2015-03-24|Medtronic Corevalve, Inc.|Delivery system for deployment of medical devices|

US8834563B2|2008-12-23|2014-09-16|Sorin Group Italia S.R.L.|Expandable prosthetic valve having anchoring appendages|

DE102009004188A1|2009-01-09|2010-07-15|Acandis Gmbh & Co. Kg|Medical implant and method of making such an implant|

US8512397B2|2009-04-27|2013-08-20|Sorin Group Italia S.R.L.|Prosthetic vascular conduit|

US20110070358A1|2009-09-20|2011-03-24|Medtronic Vascular, Inc.|Method of forming hollow tubular drug eluting medical devices|

US8808369B2|2009-10-05|2014-08-19|Mayo Foundation For Medical Education And Research|Minimally invasive aortic valve replacement|

AU2010311811B2|2009-11-02|2015-09-17|Symetis Sa|Aortic bioprosthesis and systems for delivery thereof|

US20110190776A1|2009-12-18|2011-08-04|Palmaz Scientific, Inc.|Interosteal and intramedullary implants and method of implanting same|

US9226826B2|2010-02-24|2016-01-05|Medtronic, Inc.|Transcatheter valve structure and methods for valve delivery|

US8652204B2|2010-04-01|2014-02-18|Medtronic, Inc.|Transcatheter valve with torsion spring fixation and related systems and methods|

IT1400327B1|2010-05-21|2013-05-24|Sorin Biomedica Cardio Srl|SUPPORT DEVICE FOR VALVULAR PROSTHESIS AND CORRESPONDING CORRESPONDENT.|

US8268382B2|2010-07-12|2012-09-18|Medtronic Vascular, Inc.|Method of making a stent with hollow struts|

EP2608841B1|2010-08-26|2016-12-07|Acandis GmbH & Co. KG|Electrode for medical applications, system having such an electrode, and method for producing such an electrode|

JP5874727B2|2010-09-01|2016-03-02|メドトロニックヴァスキュラーゴールウェイ|Prosthetic valve support structure|

US9333075B2|2010-09-10|2016-05-10|Symetis Sa|Valve replacement devices, delivery device for a valve replacement device and method of production of a valve replacement device|

ES2641902T3|2011-02-14|2017-11-14|Sorin Group Italia S.R.L.|Sutureless anchoring device for cardiac valve prostheses|

EP2486894B1|2011-02-14|2021-06-09|Sorin Group Italia S.r.l.|Sutureless anchoring device for cardiac valve prostheses|

WO2012127309A1|2011-03-21|2012-09-27|Ontorfano Matteo|Disk-based valve apparatus and method for the treatment of valve dysfunction|

US11045297B2|2012-10-18|2021-06-29|Vactronix Scientific Llc|Topographical features and patterns on a surface of a medical device and methods of making the same|

US9050394B2|2011-05-09|2015-06-09|Palmaz Scientific, Inc.|Method for making topographical features on a surface of a medical device|

JP2014527425A|2011-07-12|2014-10-16|ボストンサイエンティフィックサイムド，インコーポレイテッドＢｏｓｔｏｎＳｃｉｅｎｔｉｆｉｃＳｃｉｍｅｄ，Ｉｎｃ．|Linkage system for medical devices|

EP2763745A4|2011-10-04|2015-05-27|Thomas James Oxley|Sensing or stimulating activity of tissue|

US9131926B2|2011-11-10|2015-09-15|Boston Scientific Scimed, Inc.|Direct connect flush system|

US8940014B2|2011-11-15|2015-01-27|Boston Scientific Scimed, Inc.|Bond between components of a medical device|

US8951243B2|2011-12-03|2015-02-10|Boston Scientific Scimed, Inc.|Medical device handle|

US9277993B2|2011-12-20|2016-03-08|Boston Scientific Scimed, Inc.|Medical device delivery systems|

US9510945B2|2011-12-20|2016-12-06|Boston Scientific Scimed Inc.|Medical device handle|

EP2609893B1|2011-12-29|2014-09-03|Sorin Group Italia S.r.l.|A kit for implanting prosthetic vascular conduits|

WO2013112547A1|2012-01-25|2013-08-01|Boston Scientific Scimed, Inc.|Valve assembly with a bioabsorbable gasket and a replaceable valve implant|

US20130274873A1|2012-03-22|2013-10-17|Symetis Sa|Transcatheter Stent-Valves and Methods, Systems and Devices for Addressing Para-Valve Leakage|

US11207176B2|2012-03-22|2021-12-28|Boston Scientific Scimed, Inc.|Transcatheter stent-valves and methods, systems and devices for addressing para-valve leakage|

US9883941B2|2012-06-19|2018-02-06|Boston Scientific Scimed, Inc.|Replacement heart valve|

US11040230B2|2012-08-31|2021-06-22|Tini Alloy Company|Fire sprinkler valve actuator|

US10124197B2|2012-08-31|2018-11-13|TiNi Allot Company|Fire sprinkler valve actuator|

WO2014179763A1|2013-05-03|2014-11-06|Medtronic Inc.|Valve delivery tool|

US9561103B2|2013-07-17|2017-02-07|Cephea Valve Technologies, Inc.|System and method for cardiac valve repair and replacement|

CN105491978A|2013-08-30|2016-04-13|耶拿阀门科技股份有限公司|Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame|

US9901445B2|2014-11-21|2018-02-27|Boston Scientific Scimed, Inc.|Valve locking mechanism|

WO2016093877A1|2014-12-09|2016-06-16|Cephea Valve Technologies, Inc.|Replacement cardiac valves and methods of use and manufacture|

US10449043B2|2015-01-16|2019-10-22|Boston Scientific Scimed, Inc.|Displacement based lock and release mechanism|

US9861477B2|2015-01-26|2018-01-09|Boston Scientific Scimed Inc.|Prosthetic heart valve square leaflet-leaflet stitch|

US9788942B2|2015-02-03|2017-10-17|Boston Scientific Scimed Inc.|Prosthetic heart valve having tubular seal|

WO2016126524A1|2015-02-03|2016-08-11|Boston Scientific Scimed, Inc.|Prosthetic heart valve having tubular seal|

US10285809B2|2015-03-06|2019-05-14|Boston Scientific Scimed Inc.|TAVI anchoring assist device|

US10426617B2|2015-03-06|2019-10-01|Boston Scientific Scimed, Inc.|Low profile valve locking mechanism and commissure assembly|

US10080652B2|2015-03-13|2018-09-25|Boston Scientific Scimed, Inc.|Prosthetic heart valve having an improved tubular seal|

WO2016183526A1|2015-05-14|2016-11-17|Cephea Valve Technologies, Inc.|Replacement mitral valves|

EP3294220A4|2015-05-14|2019-02-13|Cephea Valve Technologies, Inc.|Cardiac valve delivery devices and systems|

US10335277B2|2015-07-02|2019-07-02|Boston Scientific Scimed Inc.|Adjustable nosecone|

US10195392B2|2015-07-02|2019-02-05|Boston Scientific Scimed, Inc.|Clip-on catheter|

US10179041B2|2015-08-12|2019-01-15|Boston Scientific Scimed Icn.|Pinless release mechanism|

US10136991B2|2015-08-12|2018-11-27|Boston Scientific Scimed Inc.|Replacement heart valve implant|

US10779940B2|2015-09-03|2020-09-22|Boston Scientific Scimed, Inc.|Medical device handle|

KR102239996B1|2015-10-20|2021-04-15|더 유니버시티 오브 멜버른|Medical devices for tissue sensing and/or stimulation|

US10342660B2|2016-02-02|2019-07-09|Boston Scientific Inc.|Tensioned sheathing aids|

US10245136B2|2016-05-13|2019-04-02|Boston Scientific Scimed Inc.|Containment vessel with implant sheathing guide|

EP3454795A1|2016-05-13|2019-03-20|JenaValve Technology, Inc.|Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath and loading system|

US10583005B2|2016-05-13|2020-03-10|Boston Scientific Scimed, Inc.|Medical device handle|

US10201416B2|2016-05-16|2019-02-12|Boston Scientific Scimed, Inc.|Replacement heart valve implant with invertible leaflets|

CN110621260A|2017-01-23|2019-12-27|科菲瓣膜技术有限公司|Replacement mitral valve|

AU2018203053B2|2017-01-23|2020-03-05|Cephea Valve Technologies, Inc.|Replacement mitral valves|

EP3573579A1|2017-01-27|2019-12-04|JenaValve Technology, Inc.|Heart valve mimicry|

CN111132726A|2017-04-18|2020-05-08|墨尔本大学|Intravascular device for sensing and/or stimulating tissue|

EP3634311A1|2017-06-08|2020-04-15|Boston Scientific Scimed, Inc.|Heart valve implant commissure support structure|

EP3661458A1|2017-08-01|2020-06-10|Boston Scientific Scimed, Inc.|Medical implant locking mechanism|

CN111225633A|2017-08-16|2020-06-02|波士顿科学国际有限公司|Replacement heart valve coaptation assembly|

US10373767B2|2017-11-21|2019-08-06|Vactronix Scientific, Llc|Structural supercapacitor composite and method of making same|

EP3720547A1|2017-12-05|2020-10-14|Vactronix Scientific, LLC|Physiologically active implantable biomaterials having engineered functional surfaces|

JP2021511144A|2018-01-19|2021-05-06|ボストンサイエンティフィックサイムド，インコーポレイテッドＢｏｓｔｏｎＳｃｉｅｎｔｉｆｉｃＳｃｉｍｅｄ，Ｉｎｃ．|Induction mode indwelling sensor for transcatheter valve system|

EP3749252A1|2018-02-07|2020-12-16|Boston Scientific Scimed, Inc.|Medical device delivery system with alignment feature|

US20200245946A1|2019-02-04|2020-08-06|Vactronix Scientific, Llc|Integrated circuit medical devices and method|

US20200269020A1|2019-02-21|2020-08-27|Vactronix Scientific, Llc|Drug-elution control sleeve for drug-eluting balloon and method|

US11058564B2|2019-02-27|2021-07-13|Vactronix Scientific Llc|Stent and method of making same|

法律状态:
2003-03-13| AS| Assignment|Owner name: ADVANCED BIO PROSTHETIC SURFACES, LTD., TEXAS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:PALMAZ, JULIO C.;SPRAGUE, EUGENE A.;SIMON, CRISTINA;AND OTHERS;REEL/FRAME:013837/0434;SIGNING DATES FROM 20030211 TO 20030228 |

2004-11-04| STCF| Information on status: patent grant|Free format text: PATENTED CASE |

2005-11-15| CC| Certificate of correction|

2008-05-22| FPAY| Fee payment|Year of fee payment: 4 |

2012-05-18| FPAY| Fee payment|Year of fee payment: 8 |

2015-08-18| AS| Assignment|Owner name: SPI DALLAS INVESTMENTS, LP, TEXAS Free format text: SECURITY INTEREST;ASSIGNORS:PALMAZ SCIENTIFIC INC.;ADVANCED BIO PROSTHETIC SURFACES, LTD.;ABPS VENTURE ONE, LTD.;REEL/FRAME:036384/0818 Effective date: 20150722 |

2015-08-24| AS| Assignment|Owner name: SPI DALLAS INVESTMENTS, LP, TEXAS Free format text: SECURITY INTEREST;ASSIGNORS:PALMAZ SCIENTIFIC INC.;ADVANCED BIO PROSTHETIC SURFACES, LTD.;ABPS VENTURE ONE, LTD.;REEL/FRAME:036434/0813 Effective date: 20150722 Owner name: LENNOX CAPITAL PARTNERS, LP, TEXAS Free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE NAME OF ASSIGNEE PREVIOUSLY RECORDED AT REEL: 036384 FRAME: 0818. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST;ASSIGNORS:PALMAZ SCIENTIFIC INC.;ADVANCED BIO PROSTHETIC SURFACES, LTD.;ABPS VENTURE ONE, LTD.;REEL/FRAME:036465/0091 Effective date: 20150722 |

2016-02-15| AS| Assignment|Owner name: PALMAZ, JULIO, CALIFORNIA Free format text: SECURITY INTEREST;ASSIGNORS:PALMAZ SCIENTIFIC INC.;ADVANCED BIO PROSTHETIC SURFACES, LTD.;ABPS VENTURE ONE, LTD.;REEL/FRAME:037820/0400 Effective date: 20150917 |

2016-02-16| AS| Assignment|Owner name: OAK COURT PARTNERS, LTD., NEVADA Free format text: SECURITY INTEREST;ASSIGNORS:PALMAZ SCIENTIFIC INC.;ADVANCED BIO PROSTHETIC SURFACES, LTD.;ABPS VENTURE ONE, LTD.;REEL/FRAME:037827/0568 Effective date: 20150917 Owner name: OAK COURT PARTNERS, LTD., NEVADA Free format text: SECURITY INTEREST;ASSIGNORS:PALMAZ SCIENTIFIC INC.;ADVANCED BIO PROSTHETIC SURFACES, LTD.;ABPS VENTURE ONE, LTD.;REEL/FRAME:037836/0646 Effective date: 20150917 |

2016-02-17| AS| Assignment|Owner name: OAK COURT PARTNERS, LTD., TEXAS Free format text: SECURITY INTEREST;ASSIGNORS:PALMAZ SCIENTIFIC INC.;ADVANCED BIO PROSTHETIC SURFACES, LTD.;ABPS VENTURE ONE, LTD.;REEL/FRAME:037839/0278 Effective date: 20151230 |

2016-07-01| REMI| Maintenance fee reminder mailed|

2016-11-23| SULP| Surcharge for late payment|Year of fee payment: 11 |

2016-11-23| FPAY| Fee payment|Year of fee payment: 12 |

2017-03-30| AS| Assignment|Owner name: VACTRONIX SCIENTIFIC, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ADVANCED BIO PROSTHETIC SURFACES, LTD.;REEL/FRAME:042117/0331 Effective date: 20160805 |

2018-05-18| AS| Assignment|Owner name: VACTRONIX SCIENTIFIC, LLC, TEXAS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:VACTRONIX SCIENTIFIC, INC.;REEL/FRAME:045846/0917 Effective date: 20180516 |

优先权:

申请号 | 申请日 | 专利标题

US09/443,929|US6379383B1|1999-11-19|1999-11-19|Endoluminal device exhibiting improved endothelialization and method of manufacture thereof|

US09/745,304|US6820676B2|1999-11-19|2000-12-22|Endoluminal device exhibiting improved endothelialization and method of manufacture thereof|US09/745,304| US6820676B2|1999-11-19|2000-12-22|Endoluminal device exhibiting improved endothelialization and method of manufacture thereof|

US10/994,770| US7625594B2|1999-11-19|2004-11-22|Endoluminal device exhibiting improved endothelialization and method of manufacture thereof|

US12/686,350| US9284637B2|1999-11-19|2010-01-12|Implantable graft and methods of making same|

US13/673,168| US9132001B2|1999-11-19|2012-11-09|Metallic implantable grafts and method of making same|

US14/852,371| US9668852B2|1999-11-19|2015-09-11|Metallic implantable grafts and method of making same|

[返回顶部]